BETHESDA, Md., April 01, 2024 Gain Therapeutics, Inc. , a clinical-stage biotechnology company leading the discovery and development of the next generation allosteric small molecule therapies,.
Gain Therapeutics (GANX) Appoints Jonas Hannestad as Chief Medical Officer streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
BETHESDA, Md., April 01, 2024 (GLOBE NEWSWIRE) Gain Therapeutics, Inc. (Nasdaq: GANX) (“Gain”, or the “Company”), a clinical-stage biotechnology company leading the discovery and development of the next generation
Exploring the mental health of Black youth in new clinical case conference series independantexpress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from independantexpress.com Daily Mail and Mail on Sunday newspapers.
June 15, 2021
The Connecticut Mental Health Center (CMHC) announces the appointment of several faculty to new positions at the center, according to Jeanne Steiner, DO, Professor of Psychiatry and Medical Director at CMHC.
Walter “Stan” Mathis, MD, Assistant Professor of Psychiatry, was appointed Medical Director of the ACT Team in 2020 and continues in the role of Associate Director of the Public Psychiatry Fellowship.
Dale Sebastian, MBBS, Assistant Professor of Psychiatry, was appointed Associate Director of the Public Psychiatry Fellowship.
Aniyizhai Annamalai, MD, Associate Professor of Psychiatry, was appointed Deputy Medical Director for Medical Services.
John Cahill, MD, PhD, Assistant Professor of Psychiatry, was appointed Deputy Medical Director for Clinical Informatics. Carmen Black (Parker), MD, Assistant Professor of Psychiatry, was appointed Medical Student Coordinator of CMHC and represents CMHC on the department’s Medical Student Education Committee.